MiRNA expression signature for potentially predicting the prognosis of ovarian serous carcinomaXiaotang Yu, Shiying Cui, Jinyao Zhao et al.|Tumor Biology|2013Cited by 67
A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER StudyNoah M. Hahn, Hristos Z. Kaimakliotis, Michael A. O’Donnell et al.|European Urology|2023Cited by 58